Cureous Labs: 10 Key Things You Must Know

Overview

Cureous Labs is an innovative medical technology startup based in Bengaluru, India, dedicated to transforming patient care through intelligent automation. Founded in 2019 as a spinoff from the prestigious Biodesign Fellowship program at AIIMS and IIT Delhi, Cureous Labs focuses on developing affordable, advanced solutions to prevent pressure injuries (bedsores) and patient falls, which are significant concerns in hospitals, rehabilitation centers, and home care environments. Their flagship product, Eturnal, is an automated patient repositioning system designed to ease the burden on caregivers while enhancing patient comfort and safety. Dive in to explore ten fascinating aspects of Cureous Labs, its cutting-edge technology, achievements, and impact on healthcare.

1. Origins and Founding

Cureous Labs was established in 2019 by Asish Mohandas, a Biodesign Fellow from AIIMS and IIT Delhi and the first National James Dyson Awardee for a medical device developed at IIT Kanpur. Born out of the School of International Biodesign’s fellowship, the company leverages a blend of healthcare innovation and user-centered design to create impactful medical technologies tailored specifically for the Indian healthcare landscape. This background lends Cureous a solid foundation of clinical insights and engineering expertise, enabling it to address critical caregiving challenges effectively.

2. Core Mission and Product Focus

At its heart, Cureous Labs aims to empower independent living through technologies that prevent pressure injuries and reduce caregiver strain. Bedsores and falls are common, debilitating problems for bedridden patients, leading to extended hospital stays and complications. Cureous carefully crafted its automated patient repositioning system Eturnal to deliver gentle, consistent repositioning without the manual labor that risks musculoskeletal disorders among caregivers. This mission embodies patient dignity, caregiver efficiency, and safety.

3. The Eturnal Automated Patient Repositioning System

Eturnal, Cureous Labs’ flagship device, offers India’s first retrofittable, automated patient turning system with advanced pressure relief features. Designed for hospitals, senior care, and homecare settings, Eturnal performs scheduled repositioning to prevent bedsores and offers fall-lock safety features. It supports customizable patient positions and remote monitoring, reducing the physical toll on nursing staff while improving patients’ comfort. Since its launch, Eturnal has been used for over 30,000 hours and has completed more than 14,000 automated patient turns, showcasing its practical impact.

4. Extensive Clinical Research and Validation

Cureous Labs’ technology stems from rigorous clinical research conducted across more than 100 hospitals in India and Australia. This multi-site research validates the effectiveness of their repositioning system in preventing pressure injuries and improving caregiver workflows. The evidence base grounds their innovation in real-world healthcare challenges, earning the trust of hospitals, rehabilitation centers, and home care providers where Cureous solutions are deployed.

5. Significant Funding and Growth

In August 2025, Cureous Labs raised ₹1.66 crore in a seed funding round led by Inflection Point Ventures (IPV), alongside Anthill Ventures. This capital infusion will enable the startup to manufacture the first batch of Eturnal devices, expand inventory, build a sales and business development team, and open its first disinfection center. Their strategic growth plans also include broadening their B2B medical tech portfolio to scale impact throughout India’s healthcare market.

6. Impact on Caregivers and Healthcare Efficiency

By automating the patient repositioning process, Cureous Labs reduces dependency on caregivers for labor-intensive turning tasks that often lead to musculoskeletal injuries among nurses. Eturnal helps alleviate caregiver fatigue and burnout, enabling more efficient use of human resources in hospitals and care facilities. This reflects a compassionate approach that benefits both patients and healthcare staff, improving overall care quality.

7. Awards and Recognitions

Cureous Labs has earned multiple national and international accolades, including prestigious grants from bodies like the Bill & Melinda Gates Foundation, BIRAC, and MeitY. The company has also received recognition as a Swissnex AIT Awardee and support from Social Alpha and the SBI Foundation, underscoring its reputation as a high-impact healthcare innovator transforming standards in patient care.

8. Market Potential and Global Relevance

The worldwide market for elderly and bedridden patient care is enormous and growing, valued at $277 billion. India alone represents a total addressable market of approximately $8.34 billion. With over 1.1 billion people aged above 60 and more than 150 million bedridden individuals globally at risk of pressure injuries, Cureous Labs is addressing a critical healthcare need with scalable solutions. Its products are competitively priced at about one-fifth the cost of international alternatives, making them accessible and relevant worldwide.

9. Diverse Product Portfolio and Future Prospects

Beyond Eturnal, Cureous Labs offers a portfolio including 'Vedge' patient support wedges and 'Layer' advanced patient turning and repositioning aids. The company is actively expanding its range of intelligent caregiving solutions catering to hospitals, senior living facilities, and homecare. Their continuous innovation pipeline and commitment to research promise ongoing contributions to automated patient care technologies, poised to evolve with emerging healthcare demands.

10. Contribution to Indian Healthcare Innovation Ecosystem

Cureous Labs exemplifies the synergy between academia and entrepreneurship within India’s growing med-tech ecosystem. As a spin-off from AIIMS and IIT Delhi’s International Biodesign program, it leverages top-tier mentorship from doctors and field experts, contributing to India’s burgeoning landscape of health-tech startups. Its success also highlights the critical role of specialized funding platforms like Inflection Point Ventures and the growing interest of investors in healthcare solutions addressing both social impact and commercial viability.

Conclusion

Cureous Labs stands at the forefront of med-tech innovation focused on a deeply challenging yet often overlooked area: pressure injury prevention and caregiver support. By combining advanced engineering with clinical research and thoughtful design, Cureous delivers affordable, effective, and intelligent solutions that transform patient care experiences and caregiver workflows. Their journey reflects the power of collaboration between top research institutions and visionary entrepreneurship, with promising prospects to impact millions of lives in India and beyond. As healthcare continues evolving, Cureous Labs invites us to rethink how technology can restore dignity and comfort in caregiving — a vital pursuit for an aging world population.